Longeveron Announces Key Additions To Its Leadership Team an

By David Willey, BenzingaLongeveron, Inc. is a clinical-stage biopharmaceutical company focused on therapies for age-related and life-threatening diseases. Longeveron’s primary drug is...

Related Keywords

Japan , Jeffrey Pfeffer , Khoso Baluch , Lisa Locklear , Nataliya Agafonova , Eli Lilly , Christine Petraglia , David Willey , Stanford University Graduate School Of Business , National Association Of Corporate Directors , Exchange Commission , Cormedix Inc , Longeveron Inc , Other Team Appointments , Nasdaq , Company Website , Avanir Pharmaceuticals , Board Member , Wa El Hashad , Chief Executive Officer , University Graduate School , Chief Medical Officer , Executive Vice President , Chief Financial Officer , Corporate Directors , Looking Statementscertain , Private Securities Litigation Reform Act , Annual Report , Markets ,